Repositive showcases Cancer Models Scout service
CAMBRIDGE, U.K.—This year’s AACR 2019 featured Repositive demonstrating its Cancer Models Scout service with an interactive app, as well as hosting a roundtable discussion on modeling cancer metastasis in preclinical drug development. Repositive’s inventory and technology enables researchers to use Cancer Models Scout to access more than 4,500 preclinical cancer models from providers worldwide. Among these are model types such as PDX models, CDX models, syngeneic and humanized mice, cell lines and 3D organoids, and these models can be used for approaches spanning from targeted therapies to immuno-oncology. Repositive’s Cancer Models Scout service is confidential.